How Much of a Cancer Drug Is Too Much? Patients, Researchers Challenge FDA-Approved Dosages

Source Summary

Patients and researchers present evidence suggesting that many FDA-approved cancer drug dosages may be excessive. They argue that reducing dosage amounts and frequency could lower costs by billions of dollars and mitigate severe side effects.